Skip to content

Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01944930
Enrollment
23
Registered
2013-09-18
Start date
2013-01-31
Completion date
2014-09-30
Last updated
2021-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal and Gynecologic Malignancies

Brief summary

Adult patients evaluated at Lahey Clinic with known or suspected gastrointestinal or gynecologic malignancies and with an indication for diagnostic laparoscopy will be offered participation in the study. The proposed study is a randomized, controlled feasibility trial with crossover design. The study's aim is to evaluate the effectiveness of laparoscopic narrow band imaging (NBI) compared to standard white-light laparoscopy for detection of peritoneal cancer metastases. Study patients will undergo laparoscopic evaluation of the peritoneal cavity using a routine white-light videolaparoscope with the capability of NBI. The order of white-light and NBI laparoscopy will be randomized for each patient (crossover design). Frozen-section histopathology biopsies will be retrieved of all suspicious-appearing abnormalities using best clinical practices. The number of detected peritoneal metastases will be compared between each diagnostic laparoscopy technique. To gauge the rate of potentially missed metastases, peritoneal cancer recurrence will be surveyed through a 1-year follow-up.

Interventions

DEVICELaparoscopic narrow band imaging
DEVICEStandard white-light laparoscopy

Sponsors

Lahey Clinic
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* adult patients * diagnosis or suspicion of malignancy of the gastrointestinal or gynecologic tract

Exclusion criteria

* clinical contraindication to diagnostic laparoscopy

Design outcomes

Primary

MeasureTime frameDescription
Rate of Detectable Peritoneal MetastasesAfter each Laparoscopy, at time of procedurenumber of additionally visualized peritoneal lesions

Countries

United States

Participant flow

Participants by arm

ArmCount
Narrow Band Imaging Laparoscopy First
Study has single cohort assessed in crossover design. In this arm NBI laparoscopy will be performed first, followed by standard white-light laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
10
Standard White-Light Laparoscopy First
Study has single cohort assessed in crossover design. In this arm standard white-light laparoscopy will be performed first, followed by NBI laparoscopy. Laparoscopic narrow band imaging Standard white-light laparoscopy
10
Total20

Baseline characteristics

CharacteristicStandard White-Light Laparoscopy FirstTotalNarrow Band Imaging Laparoscopy First
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
10 Participants20 Participants10 Participants
Age, Continuous56 years
STANDARD_DEVIATION 13
63 years
STANDARD_DEVIATION 13
70 years
STANDARD_DEVIATION 9
Region of Enrollment
United States
10 participants20 participants10 participants
Sex: Female, Male
Female
4 Participants9 Participants5 Participants
Sex: Female, Male
Male
6 Participants11 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 100 / 10
other
Total, other adverse events
0 / 100 / 10
serious
Total, serious adverse events
0 / 100 / 10

Outcome results

Primary

Rate of Detectable Peritoneal Metastases

number of additionally visualized peritoneal lesions

Time frame: After each Laparoscopy, at time of procedure

ArmMeasureValue (NUMBER)
Narrow Band Imaging LaparoscopyRate of Detectable Peritoneal Metastases0 percentage of lesions
Standard White-Light LaparoscopyRate of Detectable Peritoneal Metastases2 percentage of lesions

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026